Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-21

FDA Approved: ETODOLAC — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approves a supplemental ANDA for etodolac from Apotex Corp.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etodolac (Etodolac)

Snippet

SUPPL AP for ETODOLAC (ETODOLAC)